Meeder Advisory Services’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Meeder Advisory Services's RPRX Position: Q2 2026 in Review
Meeder Advisory Services increased its Royalty Pharma (RPRX) stake by 1.6% in Q2 2026, buying an estimated $15.3K and bringing the position to 19,242 shares worth $1.08M. The position accounts for 0.04% of the portfolio, ranked #301.
Meeder Advisory Services first reported a position in RPRX in Q4 2023 and has held it in 11 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Meeder Advisory Services held 19,242 shares of Royalty Pharma worth $1.08M as of Q2 2026.
- Meeder Advisory Services bought 294 Royalty Pharma shares in Q2 2026, an estimated $15.3K.
- Royalty Pharma made up 0.04% of Meeder Advisory Services's portfolio in Q2 2026, its #301 holding.
- Meeder Advisory Services first reported a position in Royalty Pharma in Q4 2023 and has held it in 11 quarters since.
- 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.